Gilteritinib vs salvage chemotherapy in FLT3-mutated acute myeloid leukemia: number needed to treat for clinical outcomes per a secondary analysis of the ADMIRAL trial. Issue 3 (23rd February 2022) - Zeidan, Amer M.; Qi, Cynthia Z.; Yang, Hongbo; Garnham, Andy; Shah, Manasee V.; Pandya, Bhavik J.